Senior insider sale
Chief Scientific Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$152.8K
13.56K shares
What this filing means
HEIER JEFFREY S. plans to sell 13.56K shares of OCULAR THERAPEUTIX, INC valued at approximately $152.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/2/2025ACC: 0001950047-25-007694
Officer· Chief Scientific Officer
Since Feb 2026
13.56K
Shares to sell
$152.8K
Approx. market value
10.50K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
10/1/2025
10.50KTotal acquired10.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2025 | Restricted stock vesting under a registered plan Not Applicable | 10.50K | — |
| Total | 10.50K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.06K
Market value
$36.9K
8/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.50K
Market value
$115.9K
10/2/2025
Total
Units
13.56K
Value
$152.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/25/2025 | 3.06K | $36.9K | — | Completed |
| Planned — Approximate Date | ||||
10/2/2025 | 10.50K | $115.9K | NASDAQ | Planned |
| Total | 13.56K | $152.8K | ||